Inrebic (fedratinib) - BMS
balixafortide (POL 6326) - Spexis
Jakafi (ruxolitinib) - Incyte
navitoclax (ABT 263) - AbbVie
http://www.ncbi.nlm.nih.gov/pubmed/40863873
 
Brian D Ross; Gary D Luker; Kristen Pettit; Lauren Brenner; Moshe Talpaz; Tanner H Robison; Thomas L Chenevert; Timothy D Johnson
 
Aug 27, 2025
 
Next